# Inserm

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/inserm/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 70.6 |
| Citations | 77,508,248 |
| City | Paris |
| Country | FR |
| Description | Inserm is a research organisation in Paris, FR. OpenAlex records 490,757 works and 77,508,248 citations for it. 105,393 researchers list it as their most recent affiliation. |
| Homepage | https://www.inserm.fr |
| OpenAlex ID | https://openalex.org/I154526488 |
| Region | Île-de-France |
| Researchers | 105,393 |
| ROR ID | https://ror.org/02vjkv261 |
| Type | government |
| Works | 490,757 |

## University collaborators

Showing 10 of 20.

- [Sorbonne Université](https://scholariq.org/institutions/sorbonne-universite/)
- [Université Paris Cité](https://scholariq.org/institutions/universite-paris-cite/)
- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)
- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)
- [Assistance Publique – Hôpitaux de Paris](https://scholariq.org/institutions/assistance-publique-hopitaux-de-paris/)
- [Centre de Recherche des Cordeliers](https://scholariq.org/institutions/centre-de-recherche-des-cordeliers/)
- [Harvard University](https://scholariq.org/institutions/harvard-university/)
- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)
- [Université Paris-Sud](https://scholariq.org/institutions/universite-paris-sud/)
- [Mayo Clinic in Arizona](https://scholariq.org/institutions/mayo-clinic-in-arizona/)

## University papers

Showing 12 of 2211.

- [Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/global-and-regional-mortality-from-235-causes-of-death-for-20-age-groups-in-1990/)
- [Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures](https://scholariq.org/papers/guidelines-for-the-process-of-cross-cultural-adaptation-of-self-report-measures/)
- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension/)
- [2018 ESC/ESH Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2018-esc-esh-guidelines-for-the-management-of-arterial-hypertension/)
- [The mutational constraint spectrum quantified from variation in 141,456 humans](https://scholariq.org/papers/the-mutational-constraint-spectrum-quantified-from-variation-in-141-456-humans/)
- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/2017-esc-guidelines-for-the-management-of-acute-myocardial-infarction-in/)
- [Surviving Sepsis Campaign](https://scholariq.org/papers/surviving-sepsis-campaign/)
- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure](https://scholariq.org/papers/the-effect-of-spironolactone-on-morbidity-and-mortality-in-patients-with-severe/)

## University researchers

Showing 15 of 90.

- [Bernard Iung](https://scholariq.org/researchers/bernard-iung/)
- [Philippe Gabríel Steg](https://scholariq.org/researchers/philippe-gabriel-steg/)
- [Faı̈ez Zannad](https://scholariq.org/researchers/fa-ez-zannad/)
- [Françis Guillemin](https://scholariq.org/researchers/francis-guillemin/)
- [Vlad Ratziu](https://scholariq.org/researchers/vlad-ratziu/)
- [Benjamin Besse](https://scholariq.org/researchers/benjamin-besse/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Jean‐Claude Baron](https://scholariq.org/researchers/jean-claude-baron/)
- [Philippe Ruszniewski](https://scholariq.org/researchers/philippe-ruszniewski/)
- [Yves Dauvilliers](https://scholariq.org/researchers/yves-dauvilliers/)
- [Thierry Frébourg](https://scholariq.org/researchers/thierry-frebourg/)
- [Corinne Antignac](https://scholariq.org/researchers/corinne-antignac/)
- [Pierre Ronco](https://scholariq.org/researchers/pierre-ronco/)
- [Thierry Naas](https://scholariq.org/researchers/thierry-naas/)
- [Thomas Similowski](https://scholariq.org/researchers/thomas-similowski/)

## University top topics

Showing 8 of 25.

- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.